Cholinergic neuromodulation is a candidate mechanism for aspects of arousal and attention in mammals. We have reported previously that cholinergic modulation in the primary visual cortex (V1) of the macaque monkey is strongly targeted toward GABAergic interneurons,
and in particular that the vast majority of parvalbuminimmunoreactive (PV) neurons in macaque V1 express the m1-type (pirenzepine-sensitive, Gq-coupled) muscarinic ACh receptor (m1AChR). In contrast, previous physiological data indicates that PV neurons in rats rarely express pirenzepine-sensitive muscarinic AChRs. To examine further this apparent species difference in the cholinergic effectors for the primary visual cortex, we have conducted a comparative study of the expression of m1AChRs by PV neurons in V1 of rats, guinea pigs, ferrets, macaques, and humans. We visualize PVand mAChR-immunoreactive somata by dual-immunofluorescence confocal microscopy and find that the species differences are profound; the vast majority (>75%) of PV-ir neurons in macaques, humans, and guinea pigs express m1AChRs. In contrast, in rats only 25% of the PV population is immunoreactive for m1AChRs. Our data reveal that while they do so much less frequently than in primates, PV neurons in rats do express Gqcoupled muscarinic AChRs, which appear to have gone undetected in the previous in vitro studies. Data such as these are critical in determining the species that represent adequate models for the capacity of the cholinergic system to modulate inhibition in the primate cortex. J. Comp. Neurol. 522:986-1003 , 2014 . INDEXING TERMS: striate cortex; neuromodulation; quantitative; anatomy; immunofluorescence; calcium-binding proteins; parvalbumin Neuromodulation of neocortical circuits by acetylcholine (ACh) is a candidate mechanism for aspects of arousal and attention in mammals (Muir et al., 1994; Sarter et al., 2005) . In the neocortex, ACh is usually released from varicosities that are not apposed to a synaptic specialization (Aoki and Kabak, 1992; Beaulieu and Somogyi, 1991; Umbriaco et al., 1994) , a mode of release known as volume transmission (but see Turrini et al., 2001) . Volume transmission implies that any specificity in ACh effects upon cortical circuits is likely to be conferred by selective expression of ACh receptors (AChRs). Data from both anatomical (Disney and Aoki, 2008; Disney et al., 2006 Disney et al., , 2007 and physiological studies show that, in the primary visual cortex (area V1) of the macaque monkey, cholinergic modulation is strongly targeted toward cortical inhibition. In particular, the vast majority of parvalbumin-immunoreactive (PV-ir) neurons in macaque V1 express the m1-type (pirenzepine-sensitive, Gqcoupled) muscarinic AChR (Disney and Aoki, 2008) . In contrast, previous physiological data suggest that PV-ir neurons in the neocortex of rats rarely express pirenzepine-sensitive muscarinic AChRs (Gulledge et al., 2007; Kawaguchi, 1997; Kruglikov and Rudy, 2008) . These data raise the possibility of species differences in the targets for cholinergic neuromodulation in the neocortex. Interestingly, the PV-ir population itself is known to differ both between species and between cortical areas within species. In area V1 of the macaque monkey, 74% of g-aminobutyric acid (GABA)ergic interneurons express PV (Van Brederode et al., 1990) . This contrasts with PV expression in macaque prefrontal cortex and in the rodent neocortex, where only 50% of GABAergic neurons express PV (Conde et al., 1994; Gonchar and Burkhalter, 1997) . Area V1 in macaques is also anatomically unique in other ways, including in its inhibitory neuronal population's composition, density, and distribution. For example, throughout the rest of the macaque neocortex, GABAergic interneurons comprise approximately 25% of the neuronal population, compared with only 20% in V1 (Beaulieu et al., 1992) and the composition of that population also differs from nearby visual areas (DeFelipe et al., 1999) . V1 also has a higher density of cell bodies in all primates than do other cortical areas (Collins et al., 2010) as well as smaller dendritic fields and a lower density of spines (Elston and Rosa, 1997) . It is thus not clear, when a difference is observed between macaque V1 and another cortical model system, whether that difference should be viewed as a feature of the species or of the cortical area.
Current models of visual processing are relatively well developed (compared with other sensory modalities), and visual tasks are often used in experiments designed to examine higher cognitive functions such as those subserving reward and motivation, attention, and memory. Existing visual cortical models have been developed based primarily on experiments conducted in carnivores (cats and ferrets) and primates (largely humans, macaques, and marmosets) and have strongly emphasized the primary cortex of these species. However, the power of genetic techniques has led to an increase in the use of rodent models for studying the neocortex. Species differences in visual cortical anatomy and function need to be understood in this context in order to make the most appropriate use of the data arising from the various model systems currently in use.
To examine further the possibility of species differences in the cholinergic effectors for the primary visual cortex, the expression of m1 muscarinic AChRs by PV-ir neurons in area V1 was compared between rats, guinea pigs, ferrets, macaques, and humans. Originally it was planned to examine V1 from mice as well; however, the antibody controls failed in this species. The vast majority (74-85%) of PV-ir neurons in macaques, humans, and guinea pigs express m1 AChRs. In contrast, in rats only 27%-and in ferrets 41%-of the PV-ir population are immunoreactive for m1 AChRs. These data largely agree with the results of physiological studies that have reported profound effects of cholinergic modulation on PV neurons in guinea pigs (McCormick and Prince, 1986) but not in rats (Gulledge et al., 2007; Kawaguchi, 1997) . However, the data also reveal that whereas they do so much less frequently than in primates, PV-ir neurons in rats do express Gq-coupled muscarinic AChRs, which appear to have gone undetected in the previous in vitro studies (cited above, and others) of intrinsic membrane properties and synaptic transmission.
MATERIALS AND METHODS Histological preparation
The tissue used in this study came from a number of sources; a summary of tissue sources and fixation conditions is given in Table 1 . Two (of three) rats, nine knockout mice (those generously provided by J. Wess), and all of the guinea pigs, ferrets, and macaques were perfused by one of the authors (A.D.), and details of these procedures are given below. The remaining four mice (two knockout and two wild type, generously provided by N. Nathanson), and one rat were perfused by the donor laboratories. All procedures and perfusions, by authors and donors, were performed in accordance with Institutional Guidelines for the Care and Use of Animals.
Rats
Three adult male Long Evans rats (Rattus norvegicus) were used in this study, two of which were perfused by 
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The Journal of Comparative Neurology | Research in Systems Neuroscience the following method. Anesthesia was induced with 4% isoflurane and then rats were euthanized by i.p. injection of Euthasol (2 ml; Virbac, Ft. Worth, TX). Once respiration had ceased, animals were transcardially perfused with 300 ml of chilled, heparinized 0.01 M phosphate-buffered saline (PBS; pH 7.4), followed by 400 ml of freshly prepared, chilled 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB: pH 7.4). The brains were then removed and postfixed in 4% PFA at 4 C overnight before being transferred to 30% sucrose in PBS as a cryoprotectant. Once the brains had sunk, they were sectioned in the sagittal plane at 50 lm on a freezing microtome. The third rat was exsanguinated with saline, perfused with 4% PFA, and sectioned by the donor laboratory (Chichilnisky Laboratory, Salk Institute). A one-in-six series of sections for each animal was set aside for a Nissl reference set, and the remaining tissue was transferred to PBS with 0.05% sodium azide added for storage at 4 C.
Guinea pigs
Four adult male pigmented guinea pigs (Cavia porcellus) were used in this study. Anesthesia was induced with 4% isoflurane and maintained by a single i.p. dose of ketamine (75 mg/kg) and xylazine (5 mg/kg). Once corneal and pedal reflexes were abolished, animals were transcardially perfused with 500 ml of chilled, heparinized PBS, followed by 300 ml of freshly prepared, chilled 4% PFA in PB. The brains were then removed and postfixed in 4% PFA at 4 C overnight before being transferred to 30% sucrose in PBS as a cryoprotectant. Once the brains had sunk, they were sectioned in the coronal plane at 50 lm on a freezing microtome. A one-in-six series of sections was set aside for a Nissl reference set, and the remaining tissue was transferred to PBS with 0.05% sodium azide added for storage at 4 C.
Ferrets
Three adult male ferrets (Mustela putorius) were used in this study. Anesthesia was induced with 4% isoflurane and then animals were euthanized by i.p. injection of Euthasol (3 ml). Once respiration had ceased, animals were transcardially perfused with 5-600 ml of chilled, heparinized PBS, followed by 700 ml of freshly prepared, chilled 4% PFA in PB. The brains were then removed and postfixed in 4% PFA at 4 C overnight before being transferred to 30% sucrose in PBS as a cryoprotectant. Once the brains had sunk, they were sectioned in the coronal plane at 50 lm on a freezing microtome. A one-in-six series of sections was set aside for a Nissl reference set, and the remaining tissue was transferred to PBS with 0.05% sodium azide added for storage at 4 C.
Macaques
Four adult male rhesus macaques (Macaca mulatta), one adult male cynomologous monkey (Macaca fascicularis), and one adult male pig-tailed macaque (Macaca nemestrina) were used in this study. Animals were euthanized by i.v. injection of sodium pentobarbital (65 mg/kg). Following complete abolition of corneal and pedal reflexes (M. mulatta), or electroencephalographically determined brain death (M. fascicularis, M. nemestrina), animals were transcardially perfused with 1,000 ml of chilled, heparinized PBS followed by freshly prepared, chilled 4% PFA in PB. The fixative was run for 30-40 minutes. The brains were then removed and blocked with a sagittal cut along the longitudinal fissure and a coronal cut at the anterior tip of the intraparietal sulcus. These blocks were postfixed in 4% PFA at 4 C overnight before being transferred to 30% sucrose in PBS as a cryoprotectant. Once the tissue had sunk, the region from the anterior intraparietal sulcus to occipital pole was sectioned in the coronal plane at 50 lm on a freezing microtome. Three one-in-six series of sections were set aside, one for a Nissl reference set, another for a Gallyas reference set (Gallyas, 1970) , and the third for a cytochrome oxidase reference set (Wong-Riley et al., 1998) . The remaining tissue was transferred to PBS with 0.05% sodium azide added for storage at 4 C. 
Human tissue
Five samples of human brain tissue were provided from the collection of control tissue (i.e., no pre-or postmortem evidence of neurological disorder or dementia) by Northwestern's Cognitive Neurology and Alzheimer's Disease Center (CNADC; Chicago, IL). Demographics, including postmortem interval, are presented in Table 2 . Brains were removed at the CNADC, and each hemisphere was cut into 2-4-cm blocks. These blocks were fixed in 4% PFA at 4 C for 30 hours and then taken through a sucrose gradient to 40% sucrose with 0.02% sodium azide added. Blocks containing the cuneus gyrus, approximately 4-5 cm from the occipital pole, were shipped in a small volume of PBS with 40% sucrose and 0.02% sodium azide added. Upon arrival, we sectioned the blocks at 50 lm on a freezing microtome. Two one-in-six series of sections was set aside for Nissl and cytochrome oxidase reference sets, and the remaining tissue was transferred to PBS with .05% sodium azide added for storage at 4 C.
m1/3/5 knockout mice : Wess laboratory
Nine male C57BL/6 mice (three of each genotype: m12/2, m32/2, and m52/2) were generously donated by J. Wess (National Institutes of Health, Bethesda, MD). These animals were euthanized by CO 2 inhalation. Once respiration had ceased, animals were transcardially perfused with 50 ml of chilled, heparinized PBS, followed by 50 ml of freshly prepared, chilled 4% PFA in PB. The brains were then removed and postfixed in 4% PFA at 4 C overnight before being transferred to 30% sucrose in PBS as a cryoprotectant. Once the brains had sunk, they were sectioned in the sagittal plane at 50 lm on a freezing microtome. A one-in-six series of sections was set aside for a Nissl reference set, and the remaining tissue was transferred to PBS with 0.05% sodium azide added for storage at 4 C.
m1 knockout and wild-type mice
Brains of two wild-type and two m1AChR2/2 null mice were generously donated by N. Nathanson (University of Washington, Seattle, WA). At the donor laboratory, the animals were exsanguinated with saline and perfused with 4% PFA; after postfixation, whole brains were shipped in PBS with 0.05% sodium azide added. Upon arrival, we transferred blocks to 30% sucrose in PBS as a cryoprotectant. Once the brains had sunk, they were sectioned in the sagittal plane at 50 lm on a freezing microtome. A one-in-six series of sections was set aside for a Nissl reference set, and the remaining tissue was transferred to PBS with 0.05% sodium azide added for storage at 4 C.
Source and characteristics of primary antibodies
See Table 3 for a summary of the antibodies used in this study.
The monoclonal anti-PV antibody used in this study is a mouse IgG1 produced by hybridization of mouse myeloma cells with spleen cells from mice immunized with purified PV from carp muscle (ms anti-PV: cat. #235, lot 10-11(F); Swant, Bellinzona, Switzerland). A number of polyclonal antibodies directed against the m1 AChR were screened for use in this study. Only one passed control in the key species of interest (rats and macaques). This antibody also passed controls for use in guinea pigs, ferrets, and humans. Data collection proceeded with an antibody raised in rabbit and directed against amino acids 227-353 of the human m1 muscarinic AChR (rb anti-m1: cat. #AMR-001, lot AN-05; Alomone, Jerusalem, Israel). Some of the other antibodies A companion study to investigate Gq-coupled receptor subtype substitution was planned to accompany the reported data. Antibodies directed against various epitopes on the m3 and m5 muscarinic AChRs were screened by using knockout mice and preadsorption controls. None of the antibodies passed controls.
Antigen retrieval
Antigen retrieval was used to increase the yield (immunoreactive cell bodies per unit area) and to make identification of immunoreactive neurons easier in the human tissue. Sections were incubated in 1 mM EDTA for 30 minutes at room temperature on a shaker. The vials of tissue were then placed in a water bath set at 80-95 C for 30 minutes. After removal from the water bath and 10 minutes of cooling, sections were transferred to room temperature 1 mM EDTA for a 10minute incubation on a shaker. These steps were followed by three 5-minute rinses in PBS, at which point the tissue was ready for antibody processing. This procedure increased the number of visible immunoreactive neurons per tissue section and made staining easier to distinguish from background ( Fig. 1 ) but did not alter the data on the proportion of dual-labeled neurons. Next, 243 PV-ir neurons were counted in human tissue sections (from all five subjects) that did not undergo antigen retrieval. On average, 81.4% of these PV-ir neurons were dual-labeled for the m1 muscarinic AChR (m1-ir, n 5 5 human subjects, SD 8.5%). This did not differ significantly from the result for the 602 PV-ir neurons encountered in the tissue that did undergo antigen retrieval, of which 88.6% (SD 4.7%) were m1-ir. Thus the data were combined to give 845 PV-ir neurons in total.
Antigen retrieval was only performed when immunoreactivity was to be visualized by immunofluorescence (and not when visualized by the Avidin/Biotin Complex-Peroxidase Kit with diaminobenzidine [ABC-DAB; Vector, Burlingame, CA]) and was done to make the best use of the small number of human tissue sections available. The exception to this was in conducting preadsorption controls, in which ABC-VIP (Vector) visualization was used. Antigen retrieval did not noticeably increase neuropil immunoreactivity and was not done for any other species. The mouse anti-PV and rabbit anti-m1 antibodies passed preadsorption controls (see the Antibody controls sections below) on human tissue both with and without water bath heat treatment antigen retrieval. The anti-m1 antibody did not pass preadsorption control following microwave irradiation.
Immunoperoxidase labeling
Tissue sections were processed to detect immunoreactivity for PV and for m1 muscarinic ACh receptors (mAChRs) using the ABC method. Sections for each species were always coprocessed with tissue from at least one other species (usually three or four species per processing "batch," a batch being the sections in a single well). The species that were processed together varied from batch to batch. Two or three sections per individual were chosen pseudorandomly from the tissue remaining after removal of sections for reference sets. First, the tissue was incubated in 0.3% hydrogen peroxide in 75% methanol for 20 minutes. Then, after three Staining for the m1 AChR in tissue from human area V1. In B, the tissue has not undergone heat-based antigen retrieval. The photomicrograph in D shows staining for the m1 AChR in tissue that was exposed to 1 mM EDTA and one 30minute incubation in an 80-95 C water bath prior to antibody processing. Immunoreactive neurons are much easier to identify following this treatment. A,C: Tissue processed with a preadsorbed m1 AChR antibody, in untreated (A) and heat-treated (C) tissue. In each case the tissue used for preadsorption was from the same section as that processed with the regular antibody, i.e., the section was cut in half prior to being placed in primary antibody (and therefore after heat treatment in C and D). All images are of layer 4c; note that antigen retrieval does not noticeably increase the appearance of layer 4c neuropil staining. Antibody dilution for all panels is 1:1,000. Diagonal lines represent border between layer 4c and 5. Scale bar 5 50 lm in D (applies to A-D). 5-minute rinses in PBS, the tissue was incubated for 1-2 hours in a blocking solution composed of 1% IgG-free bovine serum albumin (BSA; Jackson ImmunoResearch, West Grove, PA), 5% normal goat serum (NGS; Jackson ImmunoResearch), 0.5% Triton X-100, and 0.05% sodium azide, diluted in PBS. Primary antibodies were all diluted in blocking solution. The mouse anti-PV was diluted at 1:5,000 and the rabbit anti-m1 at 1:1,500. After blocking, the tissue sections were transferred into the diluted primary antibody and incubated overnight at room temperature on a shaker.
The following day, after three 20-minute rinses in PBS, the sections were incubated for 1-2 hours in a biotinylated F 0 ab fragment secondary antibody. Secondary antibodies were diluted in PBS containing 1% BSA. The mouse anti-PV was detected by using a goat antimouse IgG at 1:1,000 (Jackson ImmunoResearch, cat. #115-066-003, lot 76905); the rabbit anti-m1 was detected by using a goat anti-rabbit IgG at 1:2,000 (Jackson ImmunoResearch; cat. #111-066-003, lot 70900). Following this incubation and after three 5minute rinses in PBS, the sections were incubated in the Vectastain Elite ABC Kit (Vector) at room temperature on a shaker for 30-60 minutes. Another three 5-minute rinses followed, before the tissue was transferred into VIP staining solution (Vector). Staining proceeded for variable time periods (usually 2-8 minutes) and was terminated by PBS rinsing when visual inspection under a microscope indicated that good visibility of the immunoreactivity had been achieved on a low background. Sections were then mounted and dried overnight before dehydration and coverslipping (Permount, Fisher Scientific, Fair Lawn, NJ).
Immunofluorescence, dual-labeling
Dual immunofluorescence labeling was used to visualize both m1 AChRs and PV. As with the single labeling described above, sections from one species were coprocessed (i.e., in the same well) with tissue sections from at least one other species, and the specific combinations of species varied from batch to batch. This method of controlling for processing differences was not used for two of the six macaque monkeys. The data from macaque tissue coprocessed with other species did not differ from that for macaque tissue processed alone, and both replicate our previously reported result (Disney and Aoki, 2008) . Thus data from macaque tissue processed alone and macaque tissue processed with other species have been combined. On the day of staining, two sections from each individual were selected pseudorandomly and incubated in blocking solution for 1-2 hours. For immunofluorescence staining, the mouse anti-PV was used at 1:1,000 and the rabbit anti-m1 at 1:800 in blocking solution. Sections were coincubated for 24-72 hours, at room temperature on a shaker, in both antibodies concurrently. After thorough rinsing, sections were transferred into secondary antibodies (again, coincubated in a single processing step). Secondary antibodies were diluted in PBS with 1% BSA added. The mouse anti-PV was detected by using a Dylight 488-conjugated donkey anti-mouse IgG (Jackson ImmunoResearch; cat #715-486-150, lots 93947 and 95844), and the rabbit anti-m1 was detected with a Dylight 594-conjugated donkey antirabbit IgG (Jackson ImmunoResearch; cat. #711-516-152, lots 97356 and 92916). The tissue was incubated at room temperature on a shaker, protected from light, for 6-24 hours. Following thorough rinses, the sections were mounted, dried overnight in the dark, and then dehydrated and coverslipped (with DPX, Electron Microscopy Services, Hatfield, PA).
Antibody controls, primary antibodies
The antibody directed against PV has been shown previously to be specific by immunoblot of mouse brain and muscle extract (Celio et al., 1988) and does not label tissue from PV knockout mice (Schwaller et al., 1999) .
The antibody directed against the m1 AChR labels a single 78-kDa band on western blots of rat brain (manufacturer's product insert) and macaque brain (Disney et al., 2006) .
We performed preadsorption controls on all antibodies, in all species. For the human tissue, this control was undertaken for sections that had undergone antigen retrieval as well as sections that had no such pretreatment. The peptide for the m1 preadsorption control was provided by the manufacturer (Alomone). The protein for the PV preadsorption was a purified rat recombinant PV produced in E. coli (Swant, lot 5.'93) .
When the control antigens were diluted, a 40-fold molar excess (relative to IgG concentration of the antibody) was used for the rabbit anti-m1 antibody preadsorption, and a 25-fold molar excess for the mouse anti-PV. The primary antibodies were used as described in the section on immunoperoxidase labeling, and effectiveness of preadsorption was assessed by the ABC-VIP method, as described above. Antibodies were preincubated with their respective antigens for 2-3 hours at room temperature on a shaker. The preadsorbed antibodies were then used as is (i.e., without centrifugation or filtration). Preadsorption eliminated staining by both antibodies in all species tested except mice. In the other species we observed normal patterns of immunoreactivity in sections processed simultaneously according to the normal protocol, but little to no staining in
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The rabbit anti-m1 used in this study did label homozygous null m1 knockout mice (from both the Wess and Nathanson laboratories). However, this antibody also failed the preadsorption control in mice, both wild type and m12/2. These data indicate that this lot (AN-05) of the Alomone rabbit anti-m1 antibody (which is directed against an epitope from the human m1 AChR) interacts nonspecifically with unidentified protein targets in mice but not in the other species used in this study. It is thus unsurprising that the antibody also labels tissue from knockout mice: the antibody's failure in the knockout control is explicable in the context of the preadsorption control. The fact that this antibody passes preadsorption controls in the other species tested, and fails the same control in mouse, argues for its specificity in the species tested here (rat, guinea pig, ferret, macaque, human) and against the use of the knockout mouse control to evaluate this antibody in species other than mouse. Interestingly, whereas staining was completely abolished by preadsorption in guinea pigs, ferrets, macaques, and humans, a weak residual immunoreactivity was present in the rat, indicating that some level of nonspecific interaction may occur in this rodent species as well. When the preadsorption control was conducted by using immunofluorescence (IF) detection, the residual staining in rat was undetectable and thus will not have interfered with the quantification presented in this study. Switching to IF detection did not reduce the visible immunoreactivity in the mouse tissue.
It should be noted that a different lot of antibody from Alomone passed and failed controls in a different pattern across species. A polyclonal anti-m1 antibody from Millipore (Bedford, MA) also passed in a lotspecific fashion in some species (no lot from Millipore ever passed controls for use in rat, leading to its exclusion from this study), indicating variability in performance of these antibodies and highlighting the need for controls on every new lot of antibody.
Antibody controls, secondary antibodies
For each batch of processing, a control condition was included to confirm the specificity of the secondary antibodies. This involved incubating tissue sections in solutions without primary antibodies (no primary control). In these controls, sections were incubated in blocking solution for the same duration as the companion (fully processed) sections were exposed to the primary antibody. All sections were subsequently processed identically, according to the regular protocols. In the one case in which this incubation produced a fluorescent signal, all of the tissue processed in that batch was discarded.
Control experiments were also conducted in which tissue sections that had been incubated with a primary antibody were subsequently processed in a solution containing a secondary antibody. The secondary antibody targeted a different species than the host animal in which the primary antibody was raised (mismatched secondary control). In other words, the secondary antibody had no target epitope in the tissue. This procedure produced no fluorescent signal.
Confocal microscopy
Data were collected from the primary visual cortex (V1), Brodmann area 17 (Brodmann, 1909) . V1 was identified in all species by using Nissl-stained reference sections, aided by brain atlases and published data (Choudhury, 1978; McConnell and LeVay, 1986; Paxinos and Franklin, 2003; Paxinos et al., 2000; Paxinos and Watson, 2007; White et al., 1999) . The proportion of PV neurons that were immunoreactive for m1 AChRs did not differ by layer in any species in this study (see Results), as in our previous study (Disney and Aoki, 2008) . Counts are therefore reported for layers 2 and 3 (combined), layer 4 (4c in humans and macaques), layer 5, and layer 6. Layers 4a and 4b were counted in macaques and humans but did not differ from each other or from layer 4c (within species).
Using a Zeiss (Thornwood, NY) LSM 710 laser scanning confocal microscope, image montages were collected by using the Tile Scan function. For each new tissue section, laser power was chosen independently for each laser line such that with a given the laser line turned off no image was captured in the corresponding data channel. Laser power was independently determined for each tissue section. Between two and five V1 regions were imaged per tissue section. For each imaged region, two z-axis stacks were first collected using a 403 water immersion objective. The first was taken just below the layer 1/2 border (i.e., in layer 2) and the other just above the layer 6/white matter border (i.e., in layer 6). Using these stacks, an imaging plane was selected such that all cortical layers would be present in a single z-axis imaging plane. These stacks were also used to determine the average tissue thickness measure used in the Abercrombie correction for nonstereological quantification (see below) and to confirm antibody penetration throughout the thickness of the tissue. Once an imaging depth was selected, a 210-215-lm-wide scan was taken that captured the entire thickness of cortex from pia to white matter. Images were captured to two data channels concurrently, using the same 403 water immersion objective, with a pinhole size of 35.8 (1 AU). Overview scans centered on the same region with a width of 630-640 lm, aided by registration of the confocal scans with adjacent Nissl reference sections.
Determining layer boundaries
For each immunolabeled section, an adjacent Nissl reference section was used to determine layer boundaries. Digital images of the reference sections were taken with a Zeiss Axio Observer VivaTome microscope, using a 253 objective and focusing on the region adjacent (in the z axis) to each data scan. Coregistration of the fluorescence and light microscopic images was achieved by using gross morphology, pial surface shape, cutting and other artefacts, and blood vessels as fiduciary marks. The depths-in microns from the pial surface-of layers 4 (4a, b, and c in human and maca-que), 5, and 6 were recorded on the reference images. These measurements were then converted to the magnification of the data images, and the layer boundaries were drawn with a 6 10-lm confidence boundary. The depth of the boundary between layers 1 and 2 was determined by eye based on the sharp increase in the density of somata at the layer transition. Layer borders were confirmed by comparison with the staining profile for PV in which an intense band of immunoreactivity can be seen corresponding to layers 4 and 6 (4c and 6 in humans and macaques).
Counting cells
Layer boundaries were drawn onto TIFF image files using Photoshop (Adobe Systems, San Jose, CA). Counting was done using custom software written in MATLAB (MathWorks, Natick, MA). Data channels (red or green) Figure 2 . Quantification of dual immunoreactivity for parvalbumin and m1 AChRs. Each plot shows, by species (separate plots) and cortical layer (x axis) the percentage of parvalbumin-immunoreactive (PV-ir) neurons encountered in area V1 (area S1 in the far right plot) that were also immunoreactive for m1 AChRs. It can be seen that in all species there is a flat laminar profile. It can also be seen that more PV-ir neurons in humans, macaques, and guinea pigs express m1 receptors than do PV-ir neurons in ferrets or rats. Error bars represent SEM. Number of PV-ir neurons in each graph: human 5 845, macaque 5 326, guinea pig 5 355, ferret 5 203, rat V1 5 366, rat S1 5 233. Values in parentheses are the standard deviation of the mean. For each cell, n 5 10 neurons. PV-ir, parvalbumin-immunoreactive.
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The Journal of Comparative Neurology | Research in Systems Neuroscience were isolated and identified somata counted separately from gray-scale images. Only wholly visible, in-focus somata were counted. Somata that crossed the image boundary or the 20-lm confidence boundary around layer borders were excluded, as were objects smaller than 5 lm along their long axis. The x and y coordinates of the center of the cell body were recorded. Quantifications were made from small shapes (equivalent to a 5-lm object) centered at these x/y coordinates in a new image frame, i.e., in the same frame size but with the data channels turned off. The counting objects had to overlap to be counted as dually labeled. When the markings touched but did not overlap, the data channels were inspected, and a qualitative determination was made. Less than 0.2% of the sample required this additional step.
It is important to note that this study was not designed to be fully stereological in nature. In particular, tissue sections selected for processing were chosen pseudorandomly from the set of V1 sections available for a given animal rather by systematic-random methods. Additionally, we did not have access to the whole of V1 for any human subject. Our counts are therefore not exhaustive; they reflect the local densities in the counted regions and should not be taken as an unbiased representation of cell densities across the entire visual field representation in any species.
Qualitative data collection
Qualitative observations were made from both the immunoperoxidase-stained tissue and from the photomicrographs used to collect quantitative data. For nonsomatic staining, the term neuropil staining will be used. Neuropil staining includes axonal, dendritic, and punctate labeling. Axons were identified according to the presence of clearly distinguishable varicosities resembling "beads on a string" (see Figs. 4, 6, and 7 for clear examples of axonal labeling). Dendrites were identified as processes of a slightly varicose or nonvaricose nature. Additionally, we identified puncta as small spots, 1 lm or less, that were not clearly attached to a neuronal process. These puncta could represent spines, axon terminals, or "islands" of immunoreactivity along larger processes such as dendrites or axons.
Photomicrograph production
Light micrographs were captured by using a Zeiss CCD camera and AxioVision software. Brightness and contrast settings were chosen by using a live color image. The brightness and contrast were deemed optimal when the lumen of any visible vasculature appeared white, when the reaction product appeared to be the same intensity as was observable under the compound microscope, and when histograms of the color intensities were well matched across channels. Gamma correction was not used. Images were viewed offline by using Photoshop (Adobe) software. Unless noted in the figure legend, no alterations were made prior to publication Confocal images were captured by using the Zeiss Zen 2010 software package. Brightness and contrast settings were chosen using a live (false color) image and were set such that the lumen of any visible vasculature appeared black and to minimize saturation. Gamma correction was not used. Unless noted in the figure legend, the only alterations made for publication were to convert the red/green data images to magenta/green.
Analysis
This study was not stereological by design, so the Abercrombie correction (T/T1h: see Guillery, 2002) was applied to reduce the counting bias associated with soma size. Object height (h) was measured as the average diameter along the long axis of the cell soma for a random sample of 10 neurons across all layers from at least two tissue sections per species. The mean values for h are listed for each cell type and species in Table 4 .
To determine a value for T, the mean dehydrated thickness of the tissue was measured as the distance "Corrected" counts refer to the Abercrombie correction (see Materials and Methods). Percentages are calculated as means across animals within each species, with reported standard deviations, in parentheses, for this comparison across individuals. n (animals) 5 3 (rat), 4 (guinea pig), 3 (ferret), 6 (macaque), and 5 (human).
between the upper-and lower-most in-focus planes in one of the z-stacks taken at the beginning of each scan (see Confocal microscopy section above). The values obtained for T (measured across 6-10 sections per species) were as follows: rat 36.6 lm (SD 2.9), guinea pig 34.1 lm (SD 4.1), ferret 32.6 lm (SD 2.2), macaque 34.7 lm (SD 3.46), and human 31.9 lm (SD 2.7). The resulting Abercrombie correction factors for PV neurons were as follows: rat V1 0.70, rat S1 0.68, guinea pig 0.67, ferret 0.66, macaque 0.73, and human 0.67. For m1 the correction factors were rat V1 0.69, rat S1 0.69, guinea pig 0.66, ferret 0.64, macaque 0.72, and human 0.66. Both raw and corrected counts are reported in the text, all percentages are calculated based on the corrected numbers.
RESULTS
The main purpose of this study was to determine the extent to which species differences exist in the proportion of PV-ir neurons in area V1 that are also immunoreactive for the m1-type muscarinic AChR. The differences are in fact striking and exist even when tissue sections from all species are coprocessed in a sin-gle well (i.e., processing conditions are as identical as possible for such a study).
Across V1 of five species (rat, guinea pig, ferret, macaque, and human), 2,326 PV-ir neurons were counted. The raw and Abercrombie-corrected counts and resulting percentages collapsed across all cortical layers are presented in Table 4 . It can be seen that whereas guinea pigs, macaques, and humans all showed high levels of m1 AChR expression across the PV-ir population (76-85% of PV-ir neurons dual labeled), in ferret V1, far fewer PV-ir neurons were m1AChR-ir (41%) and this percentage was lower still for rat V1 (27%). A comparison with the primary somatosensory cortex in the rat indicates that this low level was not specific to V1; in area S1 of the rat, only 21% (SD 12.5) of PV-ir neurons were also immunoreactive for m1AChRs (57 of 233; 39.04 of 158.44 corrected).
Whereas brain death and exposure of the tissue to fixative occurred within a short period of time for nonhuman species, postmortem interval (PMI) was much higher for the human subjects, ranging from 4 to 12 hours across individuals. Table 2 shows the total number of PV neurons counted and the proportion of those neurons that were immunoreactive for m1 AChRs for each individual. Although the individual with the , and human (tissue processed without antigen retrieval, E). It can be seen that in each species parvalbumin-immunoreactive neurons are present in all cortical layers. (There are some in layer 1 as well, not shown here but see Fig. 4 .) There is denser staining of the neuropil and an apparently higher density of somata in the thalamic recipient layers (layers 4 and 6 in rat, guinea pig, and ferret; layers 4a, 4c, and 6 in macaque and human). The immunoreactive band in layer 4c of the human is particularly striking. Also evident is the fainter, more diffuse nature of the neuropil staining in the guinea pig, compared with all of the other species. Layer boundaries are indicated on the left of each panel. Scale bar 5 100 lm in A-E.
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A laminar profile for the dual labeling in each species is presented in Figure 2 . In all species the proportion of PV-ir neurons that were also immunoreactive for m1AChRs was roughly constant across layers, with perhaps slightly lower dual labeling for PV-ir neurons in layer 6 of the guinea pig.
Single-label immunoreactivity profiles
Immunoreactivity for PV filled much of the cell (soma, dendrites, and axon) in many, if not all, individual immunopositive cells and had a laminar profile in the neocortex (Fig. 3 ). There was a higher apparent density of neurons and often a darker staining of the neuropil in layer 4 (4a and 4c in macaques and humans) and usually in layer 6 also. This neuropil immunoreactivity, which was particularly apparent in human layer 4c (Fig. 3E) , was not noticeably increased by antigen retrieval (compare B and D of Fig. 1) . A similar broad laminar pattern was evident in all of the spe-cies studied here, but there were some variations across species and subtle differences across individuals. The general laminar pattern appeared stronger in macaques and humans and was weakest in ferrets. PVir neurons were almost never seen in layer 1, although Figure 4 shows a large PV-ir neuron encountered in layer 1 of the peripheral visual field representation (<10 degrees eccentricity) of macaque V1.
Somatic staining for PV was consistently fainter and neuropil staining more diffuse in guinea pigs than in the other species studied here (Fig. 3) . This was true even in test experiments in which a higher concentration of antibody was used in the primary incubation (up to 1:250 for immunofluorescence and 1:400 for immunoperoxidase).
The qualitative detail of m1 immunoreactivity also differed between species. In both rats and ferrets, in which the proportion of dual-labeled PV-ir neurons was lowest, there was stronger neuropil immunoreactivity than in the guinea pigs, macaques, or humans (Fig. 5) . The lower contrast difference between the somata and the neuropil evident in the panels for the rat and the ferret in Figure 5 is not a reproduction error, nor is it evidence for needed image correction; this is how the tissue appeared when viewed under the microscope.
The somatic m1 immunoreactivity, in contrast, was similar across species-a stained cytoplasmic ring around an immunonegative nuclear region with some labeling of the proximal dendrites (Figs. 5, 6) . In ferrets and rats, this somatic staining was less intense than in guinea pigs, macaques, or humans. In layer 4b of macaques and humans, there were large, intensely m1immunopositive somata.
Dual-label immunoreactivity profiles
The highly punctate nature of the nonsomatic m1 immunoreactivity makes it difficult to determine whether the m1 receptors are localized to dendrites versus axons. At the resolution of these images, even colocalization at the pixel level must be approached with caution, as pre-versus postsynaptic localization cannot be determined with confidence. However, in the rare cases in which there was a clearly m1-ir process (Fig. 6) , it was usually a dendrite. Quantification of these rare processes was not attempted, but they seemed more common in the ferret than in other species. There were certainly examples of processes that were dually labeled, and examples that were singly labeled (Fig. 6) for m1 AChRs.
An example of clearly identifiable axonal segments in this tissue is the PV-ir baskets of axon terminals surrounding m1-ir and m1-negative somata. These were common in all species in which they could be evaluated Figure 4 . A large, parvalbumin-immunoreactive neuron in layer 1 of macaque V1. Although parvalbumin neurons are rare in layer 1, they are present. Here we show a large neuron of a roughly "inverted pyramidal" morphology with its soma in layer 1. The cell's axon extends laterally through layer 1 on both sides of the soma, before turning down toward the layer to the right of the picture, although it appears a branch may continue along in layer 1 (?). Emerging from the soma is one prominent dendrite (arrow) reaching down and branching into layer 2 and across the layer1/ 2 border. There is a secondary dendrite emerging and immediately branching to the left of the soma; it appears to remain in layer 1. Scale bar 5 100 lm.
( Figs. 6A, 7) and appeared to be immunonegative for m1 AChRs.
Neuropil PV antigenicity was not well enough preserved by the immersion fixation protocol used in preparing the human samples to allow an assessment of m1 immunoreactivity in any PV-ir nonsomatic compart-ments ( Fig. 7G-I) . Although punctate PV immunoreactivity was seen, it was not associated with larger structures that would allow one to identify the puncta as being part of an axon or a dendrite. It is therefore possible that, whereas identifiable PV-ir axons in rats. ferrets, guinea pigs, and macaques were almost always Figure 5 . Qualitative comparison of immunoreactivity for m1 muscarinic acetylcholine receptors in V1 of the rat (A), guinea pig (B), ferret (C), macaque (D), and human (E). Immunoreactivity for the m1 ACh receptor in all species is characterized by a cytoplasmic ring within the cell body. The intensity of neuropil staining varies between species. In guinea pigs (B), macaques (D), and humans (E), neuropil staining is generally weaker and somatic staining appears intense. In rats (A) and ferrets (C), there is diffuse staining of the neuropil in all layers, leading to an overall darker appearance of the tissue. Note the large, strongly m1-immunoreactive somata in layer 4b, which are particularly apparent in the micrograph taken of human V1. Layer boundaries are indicated on the left of each panel. Scale bar 5 100 lm in A-E. Figure 6 . Dual labeling for m1 ACh receptors and parvalbumin in layer 5 of ferret V1. A: Isolated immunoreactivity for parvalbumin. A dense plexus of axons and dendrites is evident. B: Isolated immunoreactivity for the m1 ACh receptor. A number of labeled dendrites are visible (arrows). C: In the merged image, there is one dendrite that is clearly immunoreactive for both m1 AChRs and PV (arrowhead); this dual-labeled process appears white in the combined channel image. In this case, because there is a length of dendrite showing immunoreactivity in both channels, the possibility of a false positive is very low-this is very likely to be the dendrite of the PV neuron containing m1 receptors. There are other dendrites in this panel, which appear purely green, and are m1-immunoreactive dendrites that may or may not belong to PV neurons. Scale bar 5 50 lm in A (applies to A-C).
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Our previous study of m1 AChR expression by inhibitory and excitatory neurons in macaque V1 showed that fewer than 10% of excitatory neurons express the m1 receptor (Disney et al., 2006) . This is clearly not the case for all species included in this study. Figure 8 shows dual labeling from layer 2 of three species: ferret (Fig. 8A,D) , guinea pig (Fig. 8B,E) , and human (Fig. 8C,F) . Although we did not attempt to quantify expression by excitatory neurons, the qualitative impression is that in both ferret and guinea pig V1, many neurons that were not immunoreactive for PV expressed m1 AChRs. These singlelabeled m1-ir neurons from human V1 (Fig. 8F ) appeared sparser and of smaller size, and seemed to have a less distinctly "pyramidal" shape than did the single-labeled m1-ir neurons in ferret ( Fig. 8D ) or guinea pig (Fig. 8E) . Interestingly, Figure 8B and E, combined with the graph showing quantification of dual labeling for guinea pig (Fig. 2) , suggests that guinea pigs may actually have uniquely high levels of m1 AChR expression overall, with most neurons expressing this receptor. This is unlike the ferret and the rat, in which expression by excitatory neurons appeared to be high (Fig. 8A,B ,D,E) but expression by PV-ir neurons was low (Fig. 2) , unlike humans and macaques, in which expression by PV neurons was high ( Fig. 2) but expression by excitatory neurons appeared to be low (Fig 8C,F) .
DISCUSSION
This study shows that there are prominent species differences in the proportion of PV-ir neurons in the Figure 7 . Parvalbumin-immunoreactive perisomatic baskets are not immunoreactive for m1 ACh receptors. In these images from layer 3 of rat (A-C) and ferret (D-F) V1, a number of varicose, parvalbumin-immunoreactive perisomatic baskets are visible (for example, wide arrows in B, C, E, and F). The cell bodies inside the baskets are often m1-immunoreactive (asterisks in A, C, D, and F). In general, the varicosities that make up these baskets are not immunoreactive for m1 ACh receptors. The two strongly fluorescent points in A-C (arrowhead) may be dual-immunoreactive boutons, but they do not appear to be part of a basket. In fact their large size, lack of a connecting axon, and the striking intensity of the fluorescence in the magenta channel (A) suggest that they may be nonspecific autofluorescence. Although the staining of human V1 (G-I) was good enough to allow counting of cell bodies, neuropil immunoreactivity was not well enough preserved in these samples to assess whether parvalbumin-immunoreactive boutons express m1 ACh receptors in human V1. Scale bar 5 10 lm in C (applies to A-C), F (applies to D-F), and I (applies to G-I).
primary visual cortex that express m1-type muscarinic AChRs. The species studied here can be clustered into two groups. In the case of the first group-comprising guinea pigs, macaques, and humans-the vast majority (76% or more) of PV-ir neurons also express m1 AChRs. For the remaining two species, far fewer PV-ir neurons express these receptors, with 41% of PV-ir neurons in ferrets and only 27% in rats expressing m1 AChRs.
The possibility of membrane insertion in nonsomatic compartments
The difference in neuropil immunoreactivity-in which the neuropil of rats and ferrets is more intensely immunoreactive than the neuropil of guinea pigs, macaques, and humans-may indicate that there is a difference not only in the proportion of the PV-ir population that is m1-expressing, but also in the trafficking (or site of Figure 8 . m1 ACh receptor immunoreactivity in parvalbumin-immunonegative neurons is common in nonprimate species. A-C: Dual immunoreactivity for parvalbumin (green) and m1 AChRs (magenta) in ferret (A), guinea pig (B), and human (C) V1. It can be seen that many neurons in ferret and guinea pig V1 are singly labeled for m1 ACh receptors, whereas there appear to be fewer singly labeled m1immunoreactive neurons in human V1 (C). D-F: In the isolated channel showing m1 ACh receptor immunoreactivity (D,E), there is the appearance of a denser packing of m1-immunoreactive neurons in ferret (D) and guinea pig (E) than in human (F), and the cell bodies in D and E also appear larger and more often have a "pyramidal" appearance (example "pyramidal-like" somata marked by *). Scale bar 5 50 lm in D (applies to A,D), E (applies to B,E), and F (applies to C,F).
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The Journal of Comparative Neurology | Research in Systems Neuroscience synthesis) of the receptors. The labeling intensity of immunoreactive somata is fainter in rats and ferrets, and the labeling intensity of the neuropil is stronger, compared with the other species. We observed clear cases of immunoreactivity in dendrites (Fig. 6B , in ferret). This may indicate that the m1 AChRs being made by these cells are most likely to be membrane-inserted in a nonsomatic cellular compartment. Particularly if this is a dendritic compartment, it could explain why these receptors appear to have gone undetected in previous in vitro studies of cholinergic modulation of the intrinsic membrane properties of PV-ir neurons in rats (Gulledge et al., 2007; Kawaguchi, 1997; Kruglikov and Rudy, 2008) . It should be noted here that muscarinic receptor-mediated polarization changes in PV-ir neurons were reported in one previous in vitro study of layer 5 neurons in rat V1 (Xiang et al., 1998) ; these conflicting studies are discussed further below.
It is possible that this evidence for membrane insertion of m1 AChRs beyond the soma of PV neurons in rats and ferrets resulted in an underestimate of immunoreactive neurons in these species. This could occur if the receptors are rapidly trafficked out of the soma after synthesis, or if the receptors were in fact never in the soma, having been made in the dendrite. This can result in undetectable somatic immunoreactivity in a neuron that actually expresses a protein of interest (Burette et al., 2002) . We have shown previously that, at least in macaques, counting somata does not underestimate the population of neurons immunoreactive for muscarinic receptors, even for receptor subtypes (such as the m2 receptor) that are rarely membrane-inserted at the soma and are almost entirely trafficked out into the distal processes of the cell (Disney et al., 2006) .
Although apparent colocalization at the pixel level was evident in many images, particularly from ferret and rat V1, at the resolution of the images taken for this study such observations must be approached with caution, as there is the real possibility that the close apposition of processes that occurs at a synapse can result in a false-positive dual-labeled pixel. This can usually be ruled out in the case of immunoreactivity that traces out a section of a dendritic or axonal process (as is seen in Fig. 6B,C) , but this was usually not the case with the m1 immunoreactivity profile-which was typically highly punctate.
This question could be resolved by a future study of m1 receptor expression and localization at the electronmicroscopic level. Even if such a study were to find that the majority of PV neurons in rat and/or ferret V1 expressed m1 AChRs, but did so in the dendrite or axon, the claim of a species difference would still stand. We have shown previously, by electron micros-copy, that m1 AChRs are rarely expressed in distal processes (dendrites or axons) of any neurons in V1 of the macaque (Disney and Aoki, 2008; Disney et al., 2006) .
A lack of dual immunoreactivity is a clearer result when, as is the case with PV, one of the labels essentially fills much of the cell. Thus the lack of dualimmunolabeled varicosities in the PV-ir baskets can be taken as evidence that the release of GABA from these perisomatic structures is probably not modulated by ACh acting via m1 AChRs. It has been shown previously that ACh, acting via m2 AChRs does modulate GABA release by PV cells (Kruglikov and Rudy, 2008) .
Previous physiological findings
Our results fit well with a number of previous physiological findings. One of the earliest in vitro investigations of cholinergic modulation in the neocortex of mammals was a study of the cingulate cortex of guinea pigs (McCormick and Prince, 1986) . In those experiments, it was shown that ACh depolarized fast-spiking neurons and caused those neurons to fire action potentials. The authors further showed that a late hyperpolarization seen in adjacent pyramidal neurons following ACh application could be blocked by the GABA A receptor antagonist bicuculline. The authors did not stain for PV in these fast-spiking neurons, but given their physiological properties it is likely that they were PV-ir neurons (Kawaguchi and Kubota, 1993) . The authors did not determine which class of AChRs might underlie this effect; the present data suggest that somatic m1 receptors could well have played a role.
It has also been shown that when ACh has suppressive effects on spiking in macaque V1, these effects can also be blocked with a GABA A receptor antagonist . Given that 74% of GABAergic neurons in macaque V1 express PV (Van Brederode et al., 1990) , and PV neurons frequently innervate the cell body of their target neurons (reviewed by Markram et al., 2004) , it is likely that the suppressive effects of ACh on visual responses observed in vivo were mediated largely by PV neurons, although other interneuron subtypes could be involved. PV neurons in macaque V1 express AChRs more strongly than do excitatory neurons or calbindin-or calretinin-ir inhibitory neurons, and PV neurons express m1 AChRs more strongly than m2 AChRs (Disney and Aoki, 2008; Disney et al., 2007) . Disynaptic control of the level of inhibition-resulting from cholinergic activation of excitatory neurons that in turn drive inhibition-may add to direct effects on inhibitory neurons in vivo. However, given that fewer than 10% of excitatory neurons in macaque V1 express muscarinic AChRs (Disney et al., 2006) , this is unlikely to be a major contributing mechanism. Our finding that inhibition is a primary target for modulation of visual processing by ACh in macaques is also predicted by a recent model of cholinergic modulation in the context of a visual attention task (Deco and Thiele, 2011) .
Thus in two of the three species that are shown here to have a large population of m1 AChRexpressing PV neurons (macaques and guinea pigs), it has also been shown physiologically that ACh can induce GABA release and thereby induce suppressed firing of principal cells. Cholinergic modulation has not been studied in the ferret, but in rats it has been suggested by a number of in vitro studies that ACh does not depolarize PV neurons (which would be necessary for release of GABA, as seen in guinea pigs and macaques). There has been some debate as to what ACh does do to PV neurons in rats in vitro. Two studies have shown no membrane polarization change (i.e., neither depolarization nor hyperpolarization) in PV neurons exposed to ACh (Gulledge et al., 2007; Kawaguchi, 1997) . A third study reported that ACh could hyperpolarize PV neurons, and that it did so via muscarinic receptors. The muscarinic receptor subtype involved was not determined (Xiang et al., 1998) . It has been shown that m2 muscarinic receptors are expressed by PV neurons in rat neocortex, and that they act in their well-described manner as presynaptic inhibitors of neurotransmitter release (Kruglikov and Rudy, 2008) . If muscarinic receptors (m1 or m2 type) tend to be expressed in the axon or dendrites of PV neurons rather than at the soma-as is suggested by the weak somatic and strong neuropil staining we report-this could explain why their effects have generally been missed in studies of intrinsic membrane properties measured through in vitro whole cell patch recordings made at the soma.
Until recently there was no evidence that muscarinic receptors could act on PV neurons in rodents in a manner similar to that which we have suggested above, i.e., that ACh depolarizes PV neurons as a result of m1 AChR activation and that this depolarization causes the release of GABA. We were unable to include mice in this study (due to problems of antibody specificity), but a recent study shows that in the mouse visual cortex in vivo ACh released as a result of basal forebrain stimulation activates 25% of PV neurons, via muscarinic receptors, when the surrounding cortex is only weakly desynchronized (Alitto and Dan, 2012) . This value of 25% corresponds impressively well with the 27% of PV neurons we report as expressing m1 AChRs in the rat visual cortex.
It is important to note here that although we have shown previously that only 10% of excitatory neurons in macaques express m1 AChRs (Disney et al., 2006) , this is almost certainly not the case in all species. Although we have not quantified m1 immunoreactivity by GABAergic and non-GABAergic neurons in V1 of any species other than the macaque (and these data are also not available in the literature to our knowledge), it is clear from an inspection of the figures presented here that excitatory neurons in other species frequently express these receptors. Thus it seems likely that a further species difference exists, namely, the extent to which excitatory neurons express m1 AChRs. Quantitative anatomical confirmation of this would require a further study comparing dual labeling for m1 AChR with antibodies directed against either GABA (a study that would require different fixation conditions than were used in the present work) or glutamic acid decarboxylase (GAD) 65/67 (which in our experience has a high detection failure) and a pan-neuronal marker such as an antibody directed against NeuN. This suggestion is supported for the rat by an earlier report that between 25 and 95% (depending on cortical layer) of excitatory neurons respond to ACh (Gulledge et al., 2007) . When expressed by excitatory neurons, m1 AChRs couple to the m-current (Brown and Adams, 1980) , a potassium current that underlies spike frequency adaption. Activation of an m1 AChR with this coupling suppresses the m-current and thus increases spike rate. Thus whether net suppression or activation of cortex dominates following activation of m1 AChRs may well vary across species depending on which classes of neurons express these receptors, and to what extent.
We have reported previously that 40% of calretinin-ir neurons and 60% of calbindin-ir neurons express the m1 AChR (Disney and Aoki, 2008) . Inhibitory neurons that are not immunoreactive for PV are often subdivided using different markers in rodents-such as the 5-HT3 serotonin receptor, somatostatin, cholecystokinin, and vasoactive intestinal peptide. Although it is a matter of debate as to whether PV neurons in rat cortex respond to ACh (as discussed above), it has been shown that other interneuron types do depolarize in response to cholinergic agonists. Of particular note in this context is the observation that cholecystokinin-ir and vasoactive intestinal peptide-ir neurons are depolarized by muscarine (Kawaguchi, 1997) , and neurons such as bipolar and bitufted inhibitory neurons, which can express cholecystokinin or vasoactive intestinal peptide, can also often express calbindin or calretinin (reviewed by Markram et al., 2004) . Thus, it seems likely that these (and perhaps other) non PV-ir interneuron types in rodent cortex may often express m1 AChRs, as they do in the macaque.
Species Differences in PV Neuron Modulation
The Journal of Comparative Neurology | Research in Systems Neuroscience
